Vincent Rigby on the Need for a Canadian Foreign Human Intelligence Service | The Globe and Mail

Published: 12 May 2025

May 12, 2025 | Vincent Rigby, Slater Family Professor of Practice, alongside Stephanie Carvin and Thomas Juneau, wrote an opinion piece in The Globe and Mail urging the creation of a Canadian...

Gabriel Blanc on Rethinking Canada's Energy Future and Embracing Renewable Growth | Policy Magazine

Published: 12 May 2025

May 12, 2025 | In an op-ed for Policy Magazine, MPP '25 Gabriel Blanc critiques Prime Minister Mark Carney’s energy policy, arguing that increasing oil and gas production is a misguided approach to...

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

Published: 14 March 2025

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation...

AI analysis of healthcare records reveals key factors in autism diagnosis

Published: 26 March 2025

Scientists argue the criteria we use for diagnosing autism may need revision...

An open solution to improving research reproducibility

Published: 18 December 2024

Academic and industry scientists collaborate on a new method to characterize research antibodies

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson’s, glioblastoma and dementia  

Latest Alzheimer’s drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy...

Pages

Back to top